NewGenIvf Group Limited
NIVFNASDAQHealthcare● Active
$0.55
$-0.09(-14.51%)
Market Cap$310031
P/E Ratio—
52W High$618
52W Low$0.51
NewGenIvf Group Limited (NIVF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NIVF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.73M | $5.43M | $5.14M | $5.94M | $4.12M |
| Cost of Revenue | $3.77M | $3.61M | $3.45M | $4.41M | $3.09M |
| Gross Profit | $0.96M | $1.83M | $1.68M | $1.54M | $1.02M |
| Gross Margin %(computed) | 20.22% | 33.63% | 32.74% | 25.87% | 24.89% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $10.49M | $2.78M | $1.62M | $1.10M | $0.80M |
| Total Operating Expenses | $11.68M | $2.99M | $1.64M | $1.14M | $0.83M |
| Operating Income | ($10.73M) | ($1.16M) | $0.04M | ($0.50M) | $0.20M |
| Operating Margin %(computed) | -226.95% | -21.35% | 0.82% | -8.49% | 4.83% |
| Interest Income | $0.00M | $0.01M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.62M | $0.78M | $0.05M | $0.08M | $0.09M |
| Income Before Tax | $9.73M | ($0.96M) | $0.11M | $0.50M | $0.16M |
| Income Tax Expense | $0.00M | ($0.49M) | $0.00M | $0.21M | $0.29M |
| Net Income | $9.88M | ($0.53M) | $0.13M | $0.46M | ($0.00M) |
| Net Margin %(computed) | 209.02% | -9.66% | 2.53% | 7.72% | -0.01% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $16.80 | $-22.31 | $12.44 | $62.52 | $-0.00 |
| Wtd Avg Shares | 0.59M | 0.59M | 0.26M | 0.26M | 0.26M |
| EBITDA | $10.84M | $0.02M | $0.38M | $0.73M | $0.59M |
| EBITDA Margin %(computed) | 229.45% | 0.45% | 7.48% | 12.21% | 14.25% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more NewGenIvf Group Limited data
About NewGenIvf Group Limited (NIVF) Income Statement
NewGenIvf Group Limited (NIVF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NIVF reported revenue of $0.00B, gross profit of $0.00B (gross margin 20.22%), and net income of $0.01B — a net profit margin of 209.02%.
Frequently asked questions
NIVF · 4 questionsNewGenIvf Group Limited (NIVF) reported revenue of $0.00B for 2025, down 13.0% year-over-year.
NIVF revenueNIVF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09